What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib? Piotr RutkowskiJolanta AndrzejukJanusz A. Siedlecki Original Paper Open access 12 November 2013 Article: 765
High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse Maciej MachaczkaJan-Erik JohanssonHans Hägglund Original Paper 09 November 2013 Article: 762
Mepilex Lite dressings for managing acute radiation dermatitis in nasopharyngeal carcinoma patients: a systematic controlled clinical trial Wen-Huan ZhongQiong-Fen TangHui-Xia Feng Original Paper 02 November 2013 Article: 761
Killing of CLL and NHL cells by rituximab and ofatumumab under limited availability of complement Marcin OkrojIngrid ErikssonAnna M. Blom Original Paper 07 November 2013 Article: 759
Erratum to: Histo-biological comparative analysis of bilateral breast cancer Bilal BakerBasem MorcosMahmoud Almasri Erratum 08 November 2013 Article: 758
Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia Julhash U. KaziNuzhat N. KabirLars Rönnstrand Review Article 31 October 2013 Article: 757
RETRACTED ARTICLE: The hypoxia-inducible factor-1 regulates the microRNA185 expression through binding to hypoxia response elements sequence 2 Zhenguo SongHe RenJihui Hao Original Paper 07 November 2013 Article: 756
CK-19 mRNA-positive cells in peripheral blood predict treatment efficacy and survival in small-cell lung cancer patients Wei-Lin ShiJian LiYong-Chang Chen Original Paper 01 November 2013 Article: 755
Serum lemur tyrosine kinase 3 expression in colorectal cancer patients predicts cancer progression and prognosis Hongbing ShiJun WuJingting Jiang Original Paper 31 October 2013 Article: 754
Plasma proteomics analysis of tamoxifen resistance in breast cancer Keivan Majidzadeh-AJavad Gharechahi Original Paper 26 October 2013 Article: 753
Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study Ting DengLe ZhangYi Ba Original Paper 31 October 2013 Article: 752
MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition Xiaomei WuXiaowei XiXiaoping Wan Original Paper 26 October 2013 Article: 751
microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation Yi ShenDongfang TangHaiping Zhang Original Paper 06 November 2013 Article: 750
Expression of TMPRSS4 in patients with salivary adenoid cystic carcinoma: correlation with clinicopathological features and prognosis Wei DaiQing ZhouEnjiao Zhang Original Paper 17 October 2013 Article: 749
High level of serum AMBP is associated with poor response to paclitaxel–capecitabine chemotherapy in advanced gastric cancer patients Hao HuangYong HanChengchao Shou Original Paper 18 October 2013 Article: 748
S-1 plus CIK as second-line treatment for advanced pancreatic cancer Meng WangSheng-bin ShiJing Tian Original Paper 13 October 2013 Article: 747
Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma Xuyuan LiWen LinYingcheng Lin Original Paper 13 October 2013 Article: 746
Sequential use of mammalian target of rapamycin inhibitors in patients with metastatic renal cell carcinoma following failure of tyrosine kinase inhibitors Masafumi KumanoHideaki MiyakeMasato Fujisawa Original Paper 13 October 2013 Article: 745
An effective reinduction regimen for first relapse of adult acute lymphoblastic leukemia Ibrahim AldossVinod PullarkatDan Douer Original Paper 18 October 2013 Article: 744
Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B) Vincenzo FormicaVittore CeredaMario Roselli Original Paper 11 October 2013 Article: 743
A comparison on expression of selected biomarkers between primary lung cancers and matched metastases Dongwei GaoTiehong ZhangJiajun Du Short Communication 08 October 2013 Article: 742
Distribution of plasma fatty acids is associated with response to chemotherapy in non-Hodgkin’s lymphoma patients Zorica CvetkovićVesna VučićMarija Glibetić Original Paper 02 October 2013 Article: 741
Hemophagocytic lymphohistiocytosis (HLH): a review of literature Rohtesh S. MehtaRoy E. Smith Review Article 09 October 2013 Article: 740
Gene expression profile of the whole Mediator complex in human osteosarcoma and normal osteoblasts Concetta SchianoMonica RienzoClaudio Napoli Short Communication 08 October 2013 Article: 739
Investigation on XRCC1 genetic polymorphism and its relationship with breast cancer risk factors in Chinese women Luming ZhengFeng YangBaocheng Wang Original Paper 25 October 2013 Article: 738
Quantification of serum SOX2 DNA with FQ-PCR potentially provides a diagnostic biomarker for lung cancer Yanfeng WuXiao DuHui Chen Original Paper 15 October 2013 Article: 737
Whole-transcriptome analysis of hepatocellular carcinoma Lianjie LinDongxu WangChangqing Zheng Original Paper 18 October 2013 Article: 736
The expression and prognosis of Emi1 and Skp2 in breast carcinoma: associated with PI3K/Akt pathway and cell proliferation Xiaobing LiuHua WangQichao Ni Original Paper 25 October 2013 Article: 735
Array-CGH as an adjuvant tool in cytogenetic diagnosis of pediatric MDS and JMML Amanda Gonçalves SilvaMariana MaschiettoCarla Rosenberg Short Communication 02 October 2013 Article: 734
Comparison of serious adverse reactions between thalidomide and lenalidomide: analysis in the French Pharmacovigilance database Pascale Olivier-AbbalAnne-Charlotte TeisseyreThe French Association of Regional Pharmacovigilance Centers Original Paper 28 September 2013 Article: 733
Prognostic value of Th17 cells in acute leukemia Nashwa Khairat AbousamraManal Salah El-DinRandah Helal Original Paper Open access 02 October 2013 Article: 732
Status of antioxidant enzyme: glutathione peroxidase and total polyphenol level in plasma of Tunisian patients suffering from colorectal and gastric cancer: interaction with clinical outcome Olfa BaroudiSonia Ben YounesSoufia Chabchoub Ellouz Original Paper 27 September 2013 Article: 731
Sorafenib in combination with transarterial chemoembolization and radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma Yong LiYou-Bing ZhengLi-Gong Lu Original Paper 19 September 2013 Article: 730
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists Pierfrancesco FrancoPatrizia CiammellaAndrea Riccardo Filippi Original Paper 27 September 2013 Article: 729
p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma Asuka MurataYoshifumi BabaHideo Baba Short Communication 13 September 2013 Article: 728
Clinical implications of the tumor-infiltrating lymphocyte subsets in colorectal cancer Yunmei LiaoJuanjuan OuZhihua Ruan Short Communication 13 September 2013 Article: 727
CRM1 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas Fang ZhouWensheng QiuLu Yue Original Paper 12 September 2013 Article: 726
Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation Maciej KaźmierczakMagdalena LuczakMieczysław Komarnicki Original Paper Open access 02 October 2013 Article: 725
High level of p37δ-mRNA relative to p110δ-mRNA in neuroblastoma tumors correlates with poor patient survival Susanne FranssonKatarina Ejeskär Original Paper 12 September 2013 Article: 724
Clinical significance of serum soluble interleukin-2 receptor-α in extranodal natural killer/T-cell lymphoma (ENKTL): a predictive biomarker for treatment efficacy and valuable prognostic factor Wang LiangLiao Ding-zhunLu Yue Original Paper 15 September 2013 Article: 723
Orbital and ocular adnexal Mucosa-Associated Lymphoid Tissue (MALT) lymphomas: a single-center 10-year experience M. SmiljanicR. MilosevicB. Mihaljevic Original Paper 13 September 2013 Article: 722
Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy Shun-Jun FuShun-Li ShenBao-Gang Peng Original Paper 13 September 2013 Article: 721
Retrospective study of modified SMILE chemotherapy for advanced-stage, relapsed, or refractory extranodal natural killer (NK)/T cell lymphoma, nasal type Li YangHong LiuSheng-hua Jiang Original Paper 24 September 2013 Article: 720
Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapy Betsan M. ThomasChristian SmithJason F. Lester Original Paper 12 September 2013 Article: 719
Association of polymorphisms in FLT3, EGFR, ALOX5, and NEIL3 with glioblastoma in the Han Chinese population Tian-Bo JinXiao-Lan LiShan-Qu Li Short Communication 05 September 2013 Article: 718
Efficacy of estramustine phosphate sodium hydrate (EMP) monotherapy in castration-resistant prostate cancer patients: report of 102 cases and review of literature Kazuhiro MatsumotoNobuyuki TanakaSo Nakamura Original Paper 05 September 2013 Article: 717
Erratum to: Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer Yuan-zi YeZhi-hong ZhangYan-bei Zhang Erratum 05 September 2013 Article: 716
Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer Tao JiangHua-mei TangZhi-hai Peng Original Paper 28 September 2013 Article: 715
Expression and role of grainyhead-like 2 in gastric cancer Jifeng XiangXiang FuZiwei Wang Original Paper 26 September 2013 Article: 714
EZH2 regulates cancer cell migration through repressing TIMP-3 in non-small cell lung cancer Chunhua XuZhibo HouJun Yan Original Paper 17 October 2013 Article: 713
